Published in Clin Pharmacol Ther on January 25, 2012
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med (1997) 10.62
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol (1996) 4.45
Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med (1996) 2.32
Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain (1995) 2.29
Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol (1993) 2.23
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation (1991) 2.18
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. Ann Intern Med (2000) 1.88
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol (1994) 1.79
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension. J Clin Hypertens (Greenwich) (2001) 1.59
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up. JAMA (1998) 1.59
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59
Abrupt cessation of clonidine administration: a prospective study. Am J Cardiol (1978) 1.53
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol (1996) 1.51
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients. Ann Intern Med (1994) 1.44
Physiologic-pathologic correlation in Guillain-Barré syndrome in children. Neurology (2000) 1.43
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40
Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. Clin Pharmacol Ther (2008) 1.38
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Oxygen dependent lactate utilization by Lactobacillus plantarum. Arch Microbiol (1985) 1.31
The billowing mitral valve leaflet. Report on fourteen patients. Circulation (1968) 1.25
Parental acceptance of pediatric dentistry behavior management techniques. Pediatr Dent (1984) 1.22
Correlation of oxygen utilization and hydrogen peroxide accumulation with oxygen induced enzymes in Lactobacillus plantarum cultures. Arch Microbiol (1984) 1.20
Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium. Am J Physiol (1975) 1.18
Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia. Arch Biochem Biophys (1978) 1.15
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology (1998) 1.14
Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension (1981) 1.13
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. J Psychopharmacol (2006) 1.09
Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome. J Infect Dis (1997) 1.09
Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages. Blood (1988) 1.09
Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Transpl Infect Dis (2002) 1.08
Sensitivity of the pendulum test for assessing spasticity in persons with cerebral palsy. Dev Med Child Neurol (2000) 1.06
Onset of feedback reactions underlying vertebrate rod photoreceptor light adaptation. J Gen Physiol (1998) 1.05
Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis. Am J Trop Med Hyg (1993) 1.04
Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives. Hypertension (1998) 1.02
In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results. J Pharmacol Exp Ther (2001) 1.02
The effect of quadriceps femoris muscle strengthening exercises on spasticity in children with cerebral palsy. Phys Ther (2001) 1.02
Pathophysiologic significance of "stress" or relative polycythemia in essential hypertension. Am J Cardiol (1976) 1.00
Protection of the ischemic dog myocardium with carnitine. Am J Cardiol (1978) 1.00
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans. J Psychopharmacol (2010) 0.99
Magnesium and potassium interrelationships, experimental and clinical. Acta Med Scand Suppl (1981) 0.99
Myocardial reactive hyperemia responses in the dog after aminophylline and lidoflazine. Am J Physiol (1971) 0.97
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist. J Psychopharmacol (2010) 0.97
Clonidine withdrawal. Br J Clin Pharmacol (1979) 0.96
Evaluation of the comparative efficacy of selamectin against flea (Ctenocephalides felis felis) infestations on dogs and cats in simulated home environments. Vet Parasitol (2002) 0.95
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent. Arch Intern Med (1978) 0.95
Etiology, neurologic correlations, and prognosis in alpha coma. Clin Neurophysiol (1999) 0.95
Efficacy of selamectin against adult flea infestations (Ctenocephalides felis felis and Ctenocephalides canis) on dogs and cats. Vet Parasitol (2000) 0.93
Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril. Clin Pharmacol Ther (1983) 0.93
Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals. Am Heart J (1996) 0.92
Predicting neonatal morbidity after perinatal asphyxia: a scoring system. Am J Obstet Gynecol (1990) 0.92
Efficacy of selamectin in the treatment and prevention of flea (Ctenocephalides felis felis) infestations on dogs and cats housed in simulated home environments. Vet Parasitol (2000) 0.92
Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin. Eur J Clin Pharmacol (2005) 0.92
Equivalent dynamic human brain NK1-receptor occupancy following single-dose i.v. fosaprepitant vs. oral aprepitant as assessed by PET imaging. Clin Pharmacol Ther (2012) 0.91
Pharmacokinetics of rizatriptan in healthy elderly subjects. Int J Clin Pharmacol Ther (2001) 0.89
Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol (2001) 0.89
Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature. Arch Intern Med (1983) 0.88
Evaluation of the effects of selamectin against adult and immature stages of fleas (Ctenocephalides felis felis) on dogs and cats. Vet Parasitol (2000) 0.88
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers. J Psychopharmacol (2008) 0.88
Successful evacuation of acute pontine hematoma. Case report. J Neurosurg (1972) 0.88
Blood and skeletal levels of 210Pb-210Po as a measure of exposure to inhaled radon daughter products. Health Phys (1969) 0.88
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. J Am Coll Cardiol (1998) 0.87
Efficacy of selamectin against experimentally induced and naturally acquired ascarid (Toxocara canis and Toxascaris leonina) infections in dogs. Vet Parasitol (2000) 0.86
Antihypertensive and renal effects of tienilic acid. Postgrad Med J (1979) 0.86
Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol (1993) 0.86
Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial. J Hum Hypertens (2010) 0.86
Anterior cervical discectomy without interbody bone graft. J Neurosurg (1972) 0.85
Acceptability of various behavior management techniques relative to types of dental treatment. Pediatr Dent (1984) 0.85
Role of adenosine in reactive hyperemia of the dog heart. Experientia (1971) 0.85
Functional anatomy of the stenotic mitral valve. Br J Radiol (1972) 0.85
Prolactin isoform 2 as an autocrine growth factor for GH3 cells. Endocrinology (1992) 0.85
Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive rats. Kidney Int (1979) 0.85
Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension. J Cardiovasc Pharmacol (1987) 0.85
Size of tuberculin reactions in various age groups. Am Rev Respir Dis (1968) 0.84
Lipoprotein lipase and monoacylglycerol lipase activities during maturation of ob17 preadipocytes. Biochim Biophys Acta (1981) 0.84
The effects of salt and meclofenamate administration on the hypertension of spontaneously hypertensive rats. Clin Exp Hypertens (1980) 0.84
Renal functional and organic changes induced by salt and prostaglandin inhibition in spontaneously hypertensive rats. Nephron (1980) 0.84
Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group. J Clin Pharmacol (1995) 0.84
Myocardial metabolic activity as a determinant of reactive hyperaemia responses in the dog heart. Cardiovasc Res (1973) 0.84
[Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women]. Mol Biol (Mosk) (2006) 0.84
Neurological deficit in cats with lesions of the olivocebellar system. Arch Neurol (1971) 0.83
Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differences. Arch Intern Med (1977) 0.83
The effect of MK-0524, a prostaglandin D(2) receptor antagonist, on prostaglandin D (2)-induced nasal airway obstruction in healthy volunteers. Eur J Clin Pharmacol (2007) 0.83
Concentrations of 210Pb and 210Po in human soft tissues. Health Phys (1967) 0.82
Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort. Eur J Clin Microbiol Infect Dis (2010) 0.82
Atractyloside-induced myocardial cell injury. J Mol Cell Cardiol (1977) 0.82
Molecular mimicry in Guillain-Barré syndrome. Ann N Y Acad Sci (1998) 0.82
Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China. J Neurol Sci (1999) 0.82
Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study. Am J Hypertens (2001) 0.81
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studies. Clin Exp Hypertens (1999) 0.81
UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study. Clin Pharmacol Ther (2012) 0.81
Myocardial reactive hyperaemia responses in the dog after beta receptor block with propranolol. Cardiovasc Res (1971) 0.81
Withdrawal of antihypertensive therapy. JAMA (1978) 0.81
Effects of antipyretics on mortality due to influenza B virus in a mouse model of Reye's syndrome. Clin Invest Med (1999) 0.81
Why hypertension is so prevalent in the elderly-and how to treat it. Geriatrics (1976) 0.80
The Guillain-Barré syndrome at 75: the Campylobacter connection. Ann Neurol (1993) 0.80
Hematology and clinical chemistry parameters in the cat (Felis domesticus). J Nutr (1998) 0.80
Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. Mov Disord (2013) 0.80